GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 227 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $3,000 | -66.7% | 108 | -58.6% | 0.00% | – |
Q1 2022 | $9,000 | -71.9% | 261 | -76.4% | 0.00% | – |
Q4 2021 | $32,000 | +28.0% | 1,106 | +15.0% | 0.00% | – |
Q3 2021 | $25,000 | -16.7% | 962 | +11.1% | 0.00% | – |
Q2 2021 | $30,000 | -16.7% | 866 | -2.0% | 0.00% | – |
Q1 2021 | $36,000 | +227.3% | 884 | +233.6% | 0.00% | – |
Q4 2020 | $11,000 | -21.4% | 265 | +6.0% | 0.00% | – |
Q3 2020 | $14,000 | -22.2% | 250 | 0.0% | 0.00% | – |
Q2 2020 | $18,000 | -53.8% | 250 | -68.9% | 0.00% | -100.0% |
Q3 2019 | $39,000 | -7.1% | 805 | +0.8% | 0.00% | -50.0% |
Q2 2019 | $42,000 | – | 799 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
Grace Capital | 124,749 | $6,878,000 | 5.33% |
Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |